Analyzing Monogram Orthopaedics (MGRM) and Its Rivals

Monogram Orthopaedics (NASDAQ:MGRM) is one of 229 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it compare to its rivals? We will compare Monogram Orthopaedics to similar companies based on the strength of its dividends, institutional ownership, risk, earnings, analyst recommendations, profitability and valuation.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Monogram Orthopaedics and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Monogram Orthopaedics	0	0	0	0	N/A
Monogram Orthopaedics Competitors	1557	4232	8384	216	2.50

As a group, “Surgical & medical instruments” companies have a potential upside of 21.93%. Given Monogram Orthopaedics’ rivals higher probable upside, analysts clearly believe Monogram Orthopaedics has less favorable growth aspects than its rivals.

Institutional and Insider Ownership

0.5% of Monogram Orthopaedics shares are owned by institutional investors. Comparatively, 48.1% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 32.1% of Monogram Orthopaedics shares are owned by insiders. Comparatively, 15.1% of shares of all “Surgical & medical instruments” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Monogram Orthopaedics and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Monogram Orthopaedics	N/A	-143.70%	-83.17%
Monogram Orthopaedics Competitors	-649.87%	-420.10%	-31.28%

Earnings and Valuation

This table compares Monogram Orthopaedics and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Monogram Orthopaedics	$370,000.00	-$13.74 million	-3.09
Monogram Orthopaedics Competitors	$1.05 billion	$4.10 million	-9.70

Monogram Orthopaedics’ rivals have higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Summary

Monogram Orthopaedics rivals beat Monogram Orthopaedics on 5 of the 8 factors compared.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.